(Q33808366)

29 July 2017

1 reference

title

Recent advances in the histopathology and molecular biology of prostate cancer (English)

1 reference

29 July 2017

1 reference

1 reference

J L Burton

1

1 reference

PubMed ID

10619953

29 July 2017

N Oakley

series ordinal

2

1 reference

PubMed ID

10619953

29 July 2017

J B Anderson

series ordinal

3

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

85

1 reference

29 July 2017

1

1 reference

29 July 2017

87-94

1 reference

The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.

29 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Morphological analysis and classification of latent prostate cancer using a 3-dimensional computer algorithm: analysis of tumor volume, grade, tumor doubling time and life expectancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

The role of increasing detection in the rising incidence of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Why is the prostate cancer death rate declining in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Latest tests for prostatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

A comparison between digitally-guided fine needle aspiration and ultrasound-guided transperineal core needle biopsy of the prostate for the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Making the most out of six systematic sextant biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Incidence and clinical significance of false-negative sextant prostate biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Three-dimensional computer-assisted analysis of sector biopsy of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Observer variability in the histopathological reporting of needle biopsy specimens of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Grading and scoring in histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

The significance of intraluminal prostatic crystalloids in benign needle biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Inference network-based analyses of the histopathological effects of androgen deprivation on prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Genetic alterations in hormone-refractory recurrent prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2000.00422.X

10.1046/J.1464-410X.2000.00422.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10619953